Abeona Therapeutics (ABEO) Payables (2010 - 2026)

Abeona Therapeutics' Payables history runs 17 years deep, the most recent figure standing at $4.1 million for Q1 2026.

• In Q1 2026, Payables fell 18.87% year-over-year to $4.1 million; the TTM figure through Mar 2026 stood at $4.1 million (down 18.87% YoY), while the FY2025 annual figure was $7.9 million, up 129.26% from the prior year.
• Payables was $4.1 million for Q1 2026 at Abeona Therapeutics, down from $7.9 million in the prior quarter.
• In the past five years, Payables ranged from a high of $7.9 million in Q4 2025 to a low of $1.6 million in Q1 2022.
• Historically, Payables has averaged $3.6 million across 5 years, with a median of $3.1 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Payables slumped 58.13% in 2022, then soared 136.75% in 2025.
• A 5-year view of Payables shows it stood at $1.8 million in 2022, then climbed by 2.6% to $1.9 million in 2023, then soared by 85.2% to $3.4 million in 2024, then surged by 129.26% to $7.9 million in 2025, then sank by 48.4% to $4.1 million in 2026.
• The last three Payables figures came in at $4.1 million (Q1 2026), $7.9 million (Q4 2025), and $5.9 million (Q3 2025), per Business Quant data.